# Relates to medical use of psilocybin; appropriation

**Bill ID:** S3520A
**Session:** 2023
**Sponsor:** Nathalia Fernandez
**Status:** In Senate Committee

## Summary

Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  3520
 
  2023-2024 Regular Sessions
 
  I N  S E N A T E
 
  January 31, 2023
  ___________
 
 Introduced by Sen. FERNANDEZ -- read twice and ordered printed, and when
  printed to be committed to the Committee on Finance
 
 AN  ACT  to  amend  the  public health law and the state finance law, in
  relation to medical use of psilocybin;  and  making  an  appropriation
  therefor

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section 1. Article 33 of the public health law is amended by adding  a
 new title 5-B to read as follows:
  TITLE V-B
  MEDICAL USE OF PSILOCYBIN
 SECTION 3369-AA. DEFINITIONS.
  3369-BB. LAWFUL MEDICAL USE.
  3369-CC. CERTIFICATION OF FACILITATORS.
  3369-DD. EVALUATION; RESEARCH PROGRAMS; REPORT BY DEPARTMENT.
  3369-EE. RELATION TO OTHER LAWS.
  3369-FF. PROTECTIONS FOR THE MEDICAL USE OF PSILOCYBIN.
  3369-GG. REGULATIONS.
  3369-HH. PSILOCYBIN ASSISTED THERAPY GRANT PROGRAM.
  3369-II. NATURALLY GROWN MEDICAL PSILOCYBIN PILOT.
  3369-JJ. PSILOCYBIN ASSISTED THERAPY ADVISORY BOARD.
  §  3369-AA. DEFINITIONS. FOR THE PURPOSES OF THIS TITLE, THE FOLLOWING
 TERMS SHALL HAVE THE FOLLOWING MEANINGS:
  1.  "PSILOCYBIN"  MEANS  A  NATURALLY  OCCURRING  PSYCHEDELIC  PRODRUG
 COMPOUND  PRODUCED BY FUNGI, INCLUDING BUT NOT LIMITED TO MEMBERS OF THE
 GENUS PSILOCYBE.  SUCH TERM SHALL INCLUDE PSILOCIN, THE  SUBSTANCE  INTO
 WHICH PSILOCYBIN IS CONVERTED IN THE HUMAN BODY.
  2.  "CARING  FOR" MEANS TREATING A PATIENT, IN THE COURSE OF WHICH THE
 PRACTITIONER HAS COMPLETED A FULL ASSESSMENT OF  THE  PATIENT'S  MEDICAL
 HISTORY AND CURRENT MEDICAL CONDITION.
  3.  "CERTIFIED  MEDICAL  USE" INCLUDES USE OF MEDICAL PSILOCYBIN FOR A
 PATIENT TO TREAT OR ALLEVIATE A PATIENT'S MEDICAL CONDITION OR  SYMPTOMS
 ASSOCIATED WITH THE PATIENT'S MEDICAL CONDITION.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD07859-01-3
 S. 3520  2
 
  4.  "LICENSE"  MEANS  A  WRITTEN  AUTHORIZATION AS PROVIDED UNDER THIS
 TITLE PERMITTING PERSONS TO ENGAGE IN A  SPECIFIED  ACTIVITY  AUTHORIZED
 PURSUANT TO THIS TITLE.
  5.  "LICENSEE" MEANS AN INDIVIDUAL OR AN ENTITY WHO HAS BEEN GRANTED A
 LICENSE UNDER THIS TITLE.
  6. "MEDICAL PSILOCYBIN" MEANS  PSILOCYBIN  INTENDED  FOR  A  CERTIFIED
 MEDICAL USE, AS DETERMINED BY THE DEPARTMENT.
  7.  "FACILITATOR"  MEANS  A  MENTAL  HEALTH  COUNSELOR, PSYCHOANALYST,
 PHYSICIAN, PHYSICIAN ASSISTANT, REGISTERED PROFESSIONAL NURSE,  CLINICAL
 NURSE  SPECIALIST,  NURSE  PRACTITIONER, OCCUPATIONAL THERAPIST, OCCUPA-
 TIONAL THERAPY ASSISTANT, LICENSED CLINICAL SOCIAL WORKER, OR  AN  INDI-
 VIDUAL  WITH  EVIDENCE OF PRIOR EXPERIENCE AND KNOWLEDGE IN THE FIELD OF
 PSYCHEDELIC ASSISTED THERAPY WHO HAS COMPLETED  ALL  REQUIREMENTS  UNDER
 SECTION THIRTY-THREE HUNDRED SIXTY-NINE-CC OF THIS TITLE.
  §  3369-BB.  LAWFUL  MEDICAL  USE.  THE USE OF MEDICAL PSILOCYBIN BY A
 PATIENT FOR CERTIFIED MEDICAL USE, SHALL  BE  LAWFUL  UNDER  THIS  TITLE
 PROVIDED THAT:
  1.  THE PSILOCYBIN USED BY A PATIENT SHALL HAVE OCCURRED IN A CLINICAL
 SETTING, INCLUDING BUT NOT LIMITED  TO,  A  FACILITATOR'S  OFFICE  OR  A
 HOSPITAL,  UNDER  THE SUPERVISION OF A FACILITATOR CERTIFIED PURSUANT TO
 SECTION THIRTY-THREE HUNDRED SIXTY-NINE-CC OF THIS TITLE.  PATIENTS  WHO
 ARE  UNABLE  TO TRAVEL MAY RECEIVE PSILOCYBIN TREATMENT IN THE HOME. THE
 COURSE DEVELOPED TO CERTIFY FACILITATORS BY THE DEPARTMENT SHALL INCLUDE
 REGULATIONS AND RECOMMENDATIONS FOR CREATING  APPROPRIATE  SETTINGS  FOR
 PSILOCYBIN TREATMENT;
  2.  FACILITATORS SHALL RECEIVE PSILOCYBIN TO USE THROUGH THE NATURALLY
 GROWN MEDICAL PSILOCYBIN PILOT, PURSUANT TO SECTION THIRTY-THREE HUNDRED
 SIXTY-NINE-II  OF  THIS TITLE.  FACILITATORS WHO ARE ABLE TO ACCESS ANY
 FORTHCOMING FEDERAL FOOD  AND  DRUG  ADMINISTRATION  APPROVED  SYNTHETIC
 PSILOCYBIN PRODUCTS OR MDMA SHALL BE PERMITTED TO DO SO.
  §  3369-CC.  CERTIFICATION OF FACILITATORS.  PRIOR TO FACILITATING A
 PSILOCYBIN SESSION, A FACILITATOR SHALL COMPLETE A COURSE AS  DETERMINED
 BY THE DEPARTMENT IN REGULATION.
  §  3369-DD.  EVALUATION;  RESEARCH PROGRAMS; REPORT BY DEPARTMENT.  1.
 THE DEPARTMENT MAY PROVIDE FOR THE ANALYSIS AND EVALUATION OF THE OPERA-
 TION OF THIS TITLE. THE DEPARTMENT MAY ENTER INTO AGREEMENTS WITH ONE OR
 MORE PERSONS, NOT-FOR-PROFIT CORPORATIONS, UNIVERSITIES OR OTHER  ORGAN-
 IZATIONS, FOR THE PERFORMANCE OF AN EVALUATION OF THE IMPLEMENTATION AND
 EFFECTIVENESS OF THIS TITLE.
  2.  THE  DEPARTMENT  MAY  DEVELOP, SEEK ANY NECESSARY FEDERAL APPROVAL
 FOR, AND CARRY OUT RESEARCH PROGRAMS RELATING TO MEDICAL USE OF PSILOCY-
 BIN.  PARTICIPATION IN ANY SUCH RESEARCH PROGRAM SHALL BE  VOLUNTARY  ON
 THE PART OF FACILITATORS, PATIENTS, AND DESIGNATED CAREGIVERS.
  3.  THE  DEPARTMENT  SHALL REPORT EVERY TWO YEARS, BEGINNING TWO YEARS
 AFTER THE EFFECTIVE DATE OF THIS TITLE, TO THE GOVERNOR AND THE LEGISLA-
 TURE ON THE MEDICAL USE OF PSILOCYBIN UNDER THIS TITLE AND  MAKE  APPRO-
 PRIATE RECOMMENDATIONS.
  §  3369-EE.  RELATION  TO  OTHER LAWS. 1. THE PROVISIONS OF THIS TITLE
 SHALL APPLY, EXCEPT THAT WHERE A PROVISION OF THIS TITLE CONFLICTS  WITH
 ANOTHER PROVISION OF THIS CHAPTER, THIS TITLE SHALL APPLY.
  2.  FOR  THE  PURPOSES  OF THIS TITLE, MEDICAL PSILOCYBIN SHALL NOT BE
 DEEMED TO BE A "DRUG" FOR PURPOSES OF ARTICLE ONE  HUNDRED  THIRTY-SEVEN
 OF THE EDUCATION LAW.
  § 3369-FF. PROTECTIONS FOR THE MEDICAL USE OF PSILOCYBIN.  1. PATIENTS
 AND PRACTITIONERS AND FACILITATORS SHALL NOT BE SUBJECT TO ARREST, PROS-
 ECUTION,  OR  PENALTY  IN  ANY MANNER, OR DENIED ANY RIGHT OR PRIVILEGE,
 S. 3520  3
 
 INCLUDING BUT NOT LIMITED TO CIVIL PENALTY OR DISCIPLINARY ACTION  BY  A
 BUSINESS  OR  OCCUPATIONAL  OR  PROFESSIONAL  LICENSING BOARD OR BUREAU,
 SOLELY FOR THE CERTIFIED MEDICAL USE OF  PSILOCYBIN  OR  FOR  ANY  OTHER
 ACTION OR CONDUCT IN ACCORDANCE WITH THIS TITLE.
  2.  THIS SUBDIVISION SHALL NOT BAR THE ENFORCEMENT OF A POLICY PROHIB-
 ITING AN EMPLOYEE FROM PERFORMING HIS OR  HER  EMPLOYMENT  DUTIES  WHILE
 IMPAIRED  BY  A CONTROLLED SUBSTANCE. THIS SUBDIVISION SHALL NOT REQUIRE
 ANY PERSON OR ENTITY TO DO ANY ACT THAT WOULD PUT THE PERSON  OR  ENTITY
 IN  DIRECT  VIOLATION  OF  FEDERAL  LAW  OR  CAUSE  IT TO LOSE A FEDERAL
 CONTRACT OR FUNDING.
  3. THE FACT THAT A PERSON IS A PATIENT  AND/OR  ACTING  IN  ACCORDANCE
 WITH  THIS  TITLE, SHALL NOT BE A CONSIDERATION IN A PROCEEDING PURSUANT
 TO APPLICABLE  SECTIONS  OF  THE  DOMESTIC  RELATIONS  LAW,  THE  SOCIAL
 SERVICES LAW AND THE FAMILY COURT ACT.
  4. (A) CERTIFICATION FORMS AND ANY PATIENT INFORMATION CONTAINED WITH-
 IN  A  DATABASE  SHALL  BE  DEEMED  EXEMPT  FROM PUBLIC DISCLOSURE UNDER
 SECTIONS EIGHTY-SEVEN AND EIGHTY-NINE OF THE PUBLIC OFFICERS  LAW.  UPON
 SPECIFIC  REQUEST  BY  A PATIENT TO THE DEPARTMENT, THE DEPARTMENT SHALL
 VERIFY THE REQUESTING  PATIENT'S  STATUS  AS  A  VALID  PATIENT  TO  THE
 PATIENT'S  SCHOOL  OR  EMPLOYER  OR  OTHER  DESIGNATED  PARTY, TO ENSURE
 COMPLIANCE WITH THE PROTECTIONS AFFORDED BY THIS SECTION.
  (B) THE NAME, CONTACT INFORMATION, AND OTHER INFORMATION  RELATING  TO
 FACILITATORS  REGISTERED  WITH  THE DEPARTMENT UNDER THIS TITLE SHALL BE
 PUBLIC INFORMATION AND SHALL BE MAINTAINED ON THE  DEPARTMENT'S  WEBSITE
 ACCESSIBLE  TO THE PUBLIC IN SEARCHABLE FORM.  HOWEVER, IF A FACILITATOR
 NOTIFIES THE DEPARTMENT IN WRITING THAT HE OR SHE DOES NOT WANT  HIS  OR
 HER  NAME  AND  OTHER INFORMATION DISCLOSED, THAT FACILITATOR'S NAME AND
 OTHER INFORMATION SHALL THEREAFTER NOT BE PUBLIC  INFORMATION  OR  MAIN-
 TAINED  ON  THE DEPARTMENT'S WEBSITE, UNLESS THE FACILITATOR CANCELS THE
 REQUEST.
  5. A PERSON CURRENTLY UNDER PAROLE, PROBATION OR OTHER STATE OR  LOCAL
 SUPERVISION,  OR  RELEASED ON BAIL AWAITING TRIAL MAY NOT BE PUNISHED OR
 OTHERWISE PENALIZED FOR CONDUCT ALLOWED UNDER THIS TITLE.
  § 3369-GG. REGULATIONS. THE DEPARTMENT SHALL PROMULGATE REGULATIONS TO
 IMPLEMENT THIS TITLE.
  § 3369-HH. PSILOCYBIN ASSISTED THERAPY GRANT PROGRAM. 1.  THE  DEPART-
 MENT  SHALL ESTABLISH A PSILOCYBIN ASSISTED THERAPY GRANT PROGRAM WITHIN
 THE AMOUNT IN THE PSILOCYBIN AND MDMA  ASSISTED  THERAPY  GRANT  PROGRAM
 FUND  ESTABLISHED  UNDER  SECTION NINETY-SEVEN-UUUU OF THE STATE FINANCE
 LAW. SUCH  GRANT  PROGRAM  SHALL  PROVIDE  VETERANS,  FIRST  RESPONDERS,
 RETIRED  FIRST  RESPONDERS, AND LOW-INCOME INDIVIDUALS, WITH THE FUNDING
 NECESSARY TO RECEIVE PSILOCYBIN AND/OR MDMA  ASSISTED  THERAPY.  FUNDING
 MAY  BE  INITIALLY APPLIED TOWARD AN EXPANDED ACCESS PROGRAM APPROVED BY
 THE FEDERAL FOOD AND DRUG ADMINISTRATION PURSUANT TO 21 CFR 312 OR OTHER
 PSILOCYBIN AND/OR MDMA THERAPIES AVAILABLE PURSUANT TO THIS TITLE.  SUCH
 GRANT PROGRAM SHALL BE TERMINATED UPON THE APPROVAL OF PSILOCYBIN AND/OR
 MDMA FOR MEDICAL USE BY THE FEDERAL DRUG ENFORCEMENT ADMINISTRATION,  OR
 ANY SUCCESSOR AGENCY.
  2. THE DEPARTMENT SHALL PROMULGATE ANY NECESSARY RULES AND REGULATIONS
 FOR  THE  APPLICATION  AND  DISTRIBUTION  OF  ANY FUNDS PURSUANT TO THIS
 SECTION.
  § 3369-II. NATURALLY GROWN MEDICAL PSILOCYBIN PILOT. THE DEPARTMENT OF
 AGRICULTURE AND MARKETS SHALL ESTABLISH AND OVERSEE  THE  IMPLEMENTATION
 OF  A  PILOT  PROGRAM FOR PSILOCYBIN-CONTAINING MUSHROOMS TO BE GROWN IN
 THE STATE.  THE DEPARTMENT SHALL PROMULGATE  ALL  NECESSARY  RULES  AND
 REGULATIONS,  REGARDING  MEDICAL,  THERAPEUTIC,  OR  SUPPORTED  USE  OF
 S. 3520  4
 
 NATURALLY GROWN PSILOCYBIN MUSHROOMS.  THE  DEPARTMENT,  IN  CONJUNCTION
 WITH  THE  DEPARTMENT OF ENVIRONMENTAL CONSERVATION, SHALL ESTABLISH AND
 IMPLEMENT A PROCESS FOR  APPROVAL,  GOVERNING  THE  SAFE  PRODUCTION  OF
 PSILOCYBIN,  INCLUDING,  BUT  NOT  LIMITED  TO, ENVIRONMENTAL AND ENERGY
 STANDARDS AND RESTRICTIONS ON THE USE OF  PESTICIDES.  THE  DEPARTMENT
 SHALL  MAKE  A  GOOD FAITH EFFORT TO WORK WITH THE FEDERAL DEPARTMENT OF
 JUSTICE AND DRUG ENFORCEMENT AGENCY TO RECEIVE  PUBLIC  HEALTH  RESEARCH
 EXEMPTION  FROM  THE  CONTROLLED SUBSTANCES ACT UNDER SECTION 872 (E) OR
 ANY SIMILAR PROVISION. ACCREDITED UNIVERSITIES AND COLLEGES  WITHIN  THE
 STATE  MAY  APPLY TO THE DEPARTMENT TO PARTICIPATE IN PILOT CULTIVATION,
 TREATMENT, AND RESEARCH PROGRAMS.
  § 3369-JJ. PSILOCYBIN ASSISTED THERAPY ADVISORY BOARD. 1. THE PSILOCY-
 BIN ASSISTED THERAPY ADVISORY BOARD OR "ADVISORY BOARD"  IS  ESTABLISHED
 WITHIN  THE DEPARTMENT TO ADVISE AND ISSUE RECOMMENDATIONS ON THE USE OF
 MEDICAL PSILOCYBIN IN THE STATE OF NEW YORK.
  2. (A) THE ADVISORY BOARD SHALL CONSIST OF THIRTEEN  VOTING  APPOINTED
 MEMBERS, ALONG WITH THE FOLLOWING MEMBERS SERVING AS NON-VOTING EX-OFFI-
 CIO  MEMBERS:  (I)  THE COMMISSIONER, OR HIS OR HER DESIGNEE; AND (II) A
 REPRESENTATIVE FROM THE DEPARTMENT WHO IS FAMILIAR  WITH  PUBLIC  HEALTH
 PROGRAMS AND PUBLIC HEALTH ACTIVITIES IN THE STATE.
  (B)  THE GOVERNOR SHALL HAVE SEVEN APPOINTMENTS, AT LEAST ONE OF WHICH
 SHALL BE A MEMBER OF A FEDERALLY RECOGNIZED NATIVE AMERICAN  TRIBE,  THE
 TEMPORARY  PRESIDENT OF THE SENATE AND THE SPEAKER OF THE ASSEMBLY SHALL
 EACH HAVE THREE APPOINTMENTS TO THE BOARD. ADVISORY BOARD MEMBERS  SHALL
 HAVE STATEWIDE GEOGRAPHIC REPRESENTATION THAT IS BALANCED AND DIVERSE IN
 ITS COMPOSITION. APPOINTED MEMBERS SHALL HAVE AN EXPERTISE IN PUBLIC AND
 BEHAVIORAL HEALTH, SUBSTANCE USE DISORDER TREATMENT, PSILOCYBIN-ASSISTED
 THERAPY  RESEARCH,  MDMA-ASSISTED THERAPY RESEARCH AND/OR CLINICAL PRAC-
 TICE, TRAUMA AND MENTAL HEALTH, ACCESS TO CARE IN  UNDERSERVED  COMMUNI-
 TIES, VETERAN MENTAL HEALTH CARE, AND HARM REDUCTION.
  3.  THE MEMBERS SHALL BE APPOINTED TO THE ADVISORY BOARD TO EACH SERVE
 FOUR-YEAR TERMS AND IN THE EVENT OF A  VACANCY,  THE  VACANCY  SHALL  BE
 FILLED  IN  THE  MANNER OF THE ORIGINAL APPOINTMENT FOR THE REMAINDER OF
 THE TERM. THE APPOINTED MEMBERS AND  REPRESENTATIVES  SHALL  RECEIVE  NO
 COMPENSATION  FOR  THEIR  SERVICES BUT SHALL BE ALLOWED THEIR ACTUAL AND
 NECESSARY EXPENSES INCURRED IN THE PERFORMANCE OF THEIR DUTIES AS  BOARD
 MEMBERS.
  4.  THE  CHAIRPERSON  OF  THE  ADVISORY BOARD AND THE VICE CHAIRPERSON
 SHALL BE ELECTED FROM AMONG THE MEMBERS OF THE  ADVISORY  BOARD  BY  THE
 MEMBERS OF SUCH ADVISORY BOARD. THE VICE CHAIRPERSON SHALL REPRESENT THE
 ADVISORY  BOARD  IN THE ABSENCE OF THE CHAIRPERSON AT ALL OFFICIAL ADVI-
 SORY BOARD FUNCTIONS.
  5. THE ADVISORY BOARD SHALL ENACT AND FROM  TIME  TO  TIME  MAY  AMEND
 BYLAWS  OR  RULES IN RELATION TO ITS MEETINGS AND THE TRANSACTION OF ITS
 BUSINESS. THE BOARD MAY  ALSO  ESTABLISH  COMMITTEES  AND  SUBCOMMITTEES
 NECESSARY  FOR  THE  OPERATION  OF  THE  BOARD.  THE ADVISORY BOARD IS
 EXPECTED TO WORK WITH ESTABLISHED  RELIGIOUS,  CULTURAL  AND  COMMUNITY-
 BASED  PSILOCYBIN  GROUPS  AND  CULTIVATORS  ON  RECOMMENDATIONS  TO THE
 DEPARTMENT REGARDING GUIDELINES FOR SAFE AND EFFECTIVE SERVICES,  SAFETY
 STANDARDS, INDUSTRY BEST PRACTICES, CODE OF PROFESSIONAL CONDUCT, EDUCA-
 TION,  TRAINING,  AND EXAMINATION FOR FACILITATORS, PRODUCTION, AND LONG
 TERM STRATEGIC PLANS FOR SERVICE.  A MAJORITY OF THE  TOTAL  NUMBER  OF
 VOTING MEMBERS WHICH THE BOARD WOULD HAVE WERE THERE NO VACANCIES, SHALL
 CONSTITUTE A QUORUM AND SHALL BE REQUIRED FOR THE BOARD TO CONDUCT BUSI-
 NESS.  ALL  MEETINGS OF THE ADVISORY BOARD SHALL BE CONDUCTED IN ACCORD-
 ANCE WITH THE PROVISIONS OF ARTICLE SEVEN OF THE PUBLIC OFFICERS LAW.
 S. 3520  5
 
  6. (A) WITHIN THE FIRST TWO YEARS OF THE ESTABLISHMENT OF THE ADVISORY
 BOARD, THE BOARD SHALL MEET AT LEAST ONCE EVERY CALENDAR MONTH AT A TIME
 AND PLACE DETERMINED BY THE CHAIRPERSON OR  A  MAJORITY  OF  THE  VOTING
 MEMBERS  OF  THE  BOARD.  AFTER  THE FIRST TWO YEARS, THE ADVISORY BOARD
 SHALL  MEET  AT  LEAST  ONCE  EVERY CALENDAR QUARTER AT A TIME AND PLACE
 DETERMINED BY THE CHAIRPERSON OR A MAJORITY OF THE VOTING MEMBERS OF THE
 BOARD. THE ADVISORY BOARD MAY ALSO MEET AT OTHER TIMES AND PLACES SPECI-
 FIED BY THE CALL OF THE CHAIRPERSON OR  OF  A  MAJORITY  OF  THE  VOTING
 MEMBERS OF THE BOARD.
  (B)  AFTER THE FIRST YEAR OF THE PROGRAM'S IMPLEMENTATION, THERE SHALL
 BE:  (I) A PROGRAM AUDIT INCORPORATING  PATIENT  FEEDBACK;  AND  (II)  A
 STATE  AND INDEPENDENT REVIEW OF EFFICACY, EFFICIENCY, COST, AND EQUITY.
 THE AUDIT WILL INCLUDE CONSIDERATION OF WHETHER AND HOW TO EXPAND PSILO-
 CYBIN ACCESS, PROVIDED THAT THE PILOT PROGRAM RESULTS ARE SUCCESSFUL.
  7. THE ADVISORY BOARD SHALL HAVE THE FOLLOWING DUTIES:
  (A) PROVIDE ADVICE TO THE DEPARTMENT REGARDING THE PROVISIONS OF  THIS
 TITLE  AND  MAKE  RECOMMENDATIONS  ON  AVAILABLE MEDICAL, PSYCHOLOGICAL,
 SCIENTIFIC STUDIES, RESEARCH AND OTHER INFORMATION RELATING TO THE SAFE-
 TY AND EFFICACY OF PSILOCYBIN  IN  TREATING  MENTAL  HEALTH  CONDITIONS,
 INCLUDING  BUT  NOT  LIMITED TO ADDICTION, DEPRESSION, ANXIETY DISORDERS
 AND END-OF-LIFE PSYCHOLOGICAL DISTRESS.
  (B) MAKE RECOMMENDATIONS TO THE DEPARTMENT ON THE REQUIREMENTS,  SPEC-
 IFICATIONS AND GUIDELINES FOR PROVIDING PSILOCYBIN SERVICES TO A CLIENT.
  (C) MAKE RECOMMENDATIONS TO THE DEPARTMENT ON PUBLIC HEALTH AND SAFETY
 STANDARDS AND INDUSTRY BEST PRACTICES UNDER THIS TITLE.
  (D)  DEVELOP  A  LONG-TERM STRATEGIC PLAN FOR ENSURING THAT PSILOCYBIN
 SERVICES WILL BECOME AND REMAIN A SAFE, ACCESSIBLE AND AFFORDABLE THERA-
 PEUTIC OPTION FOR ALL PERSONS EIGHTEEN YEARS OF AGE  AND  OLDER  IN  THE
 STATE FOR WHOM PSILOCYBIN SERVICES MAY BE APPROPRIATE.
  (E) MONITOR AND STUDY FEDERAL LAWS, REGULATIONS AND POLICIES REGARDING
 PSILOCYBIN.
  (F)  ADVISE  ON  AND  HELPING  DEVELOP  PUBLIC AWARENESS AND EDUCATION
 CAMPAIGNS.
  § 2. The state finance law is amended by adding a new section  97-uuuu
 to read as follows:
  § 97-UUUU. PSILOCYBIN AND MDMA ASSISTED THERAPY GRANT PROGRAM FUND. 1.
 THERE  IS HEREBY ESTABLISHED IN THE JOINT CUSTODY OF THE COMMISSIONER OF
 HEALTH AND THE COMPTROLLER A FUND TO BE KNOWN  AS  THE  "PSILOCYBIN  AND
 MDMA ASSISTED THERAPY GRANT PROGRAM FUND".
  2.  THE FUND SHALL CONSIST OF ALL MONIES APPROPRIATED FOR ITS PURPOSE,
 AND ALL MONIES REQUIRED BY THIS SECTION OR ANY OTHER PROVISION OF LAW TO
 BE PAID INTO OR CREDITED TO SUCH FUND. THE FUND SHALL  NOT  CONTAIN  ANY
 MONIES WHICH ARE NOT INTENDED FOR THE FUND.
  3.  MONIES  SHALL BE PAYABLE FROM THE FUND ON THE AUDIT AND WARRANT OF
 THE STATE COMPTROLLER ON VOUCHERS APPROVED AND CERTIFIED BY THE  COMMIS-
 SIONER OF HEALTH.
  §  3. The sum of five million dollars ($5,000,000), or so much thereof
 as may be necessary, is hereby appropriated to the psilocybin  and  MDMA
 assisted  therapy or P.A.T grant program fund, established under section
 97-uuuu of the state finance law, out of any moneys in the state  treas-
 ury in the general fund, not otherwise appropriated, and made immediate-
 ly  available,  for  the  purpose of carrying out the provisions of this
 act. Such moneys shall be payable on the audit and warrant of the  comp-
 troller  on vouchers certified or approved by the commissioner of health
 in the manner prescribed by law.
  § 4. This act shall take effect immediately.